VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

JAMA Editor’s Summary

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the

December 15, 2020

Listen on your favorite player Take me to this show’s page

Newer →

Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

← Older

Omega-3 Fatty Acids for CVD Prevention, Co-trimaxazole (TMP/SMX) for IPF, Asthma Management Guidelines, and more

Facebook Twitter Buffer LinkedIn WhatsApp

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 15, 2020 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00